Table 2 Positive rate of pancreatic cancer versus benign pancreatic disease
From: Multiple tumor marker protein chip detection system in diagnosis of pancreatic cancer
Pancreatic cancer | Benign pancreatic disease | |
|---|---|---|
(n =235) | (n =230) | |
CA19-9 (U/ml) | 49.3% | 14.2% |
CA125 (U/ml) | 47.3% | 13.6% |
FER (ng/ml) | 43.2% | 49.2% |
CA242 (U/ml) | 42.7% | 23.6% |
CEA (ng/ml) | 36.4% | 14.8% |
CA15-3 (U/ml) | 28.7% | 0 |
β-HCG (mIU/ml) | 25.5% | 0 |
AFP (ng/ml) | 20.4% | 0 |
NSE (ng/ml) | 18.9% | 0 |
PSA (ng/ml) | 13.5% | 0 |
f-PSA (ng/ml) | 14.1% | 0 |